Abstract
The efficacy of antipyretics for preventing febrile seizure recurrence has been reported by a recent study, and the results might overturn previous evidence. We systematically reviewed the efficacy of antipyretics in the prevention of febrile seizure recurrence in children focused on the timing of its administration. We searched the Medline, Embase, and Cochrane Central Register of Controlled Trials databases for randomized and quasi-randomized trials and prospective non-randomized studies of aged up to 60 months, diagnosed with febrile seizure, who were treated with antipyretics. Data were extracted from eight studies. Only one study reported that antipyretics prevented the recurrence of febrile seizures within the same fever episode (9.1% in the acetaminophen group vs. 23.5% in the control group, p < 0.01). Four studies found no evidence for the efficacy of antipyretics in preventing febrile seizure recurrence in distant fever episodes (odds ratio, 0.92; 95% confidence interval, 0.57–1.48, for two randomized controlled studies).
Conclusion: This review provides very limited support for the use of antipyretics in preventing febrile seizure recurrence within the same fever episode and no evidence for its use in distant fever episodes. New studies are required to evaluate this topic further and determine whether the effectiveness of antipyretics is based on intervention timing.
What is Known: • Reviews of prophylactic drug management among febrile seizure children found that antipyretics had no significant benefits. • Recent data suggest that antipyretics are effective in preventing febrile seizures. | |
What is New: • Weak evidence suggests a possible role in preventing febrile seizure recurrence within the same fever episode. • There is clearly no role for antipyretic prophylaxis in preventing febrile seizures during distant fever episodes. |
This is a preview of subscription content, access via your institution.




Abbreviations
- RCT:
-
Randomized control trials
References
Hauser WA (1994) The prevalence and incidence of convulsive disorders in children. Epilepsia. 35(Suppl 2):S1–S6
Vestergaard M, Pedersen CB, Sidenius P, Olsen J, Christensen J (2007) The long-term risk of epilepsy after febrile seizures in susceptible subgroups. Am J Epidemiol 165:911–918. https://doi.org/10.1093/aje/kwk086
Hirabayashi Y, Okumura A, Kondo T, Magota M, Kawabe S, Kando N, Yamaguchi H, Natsume J, Negoro T, Watanabe K (2009) Efficacy of a diazepam suppository at preventing febrile seizure recurrence during a single febrile illness. Brain and Development 31:414–418. https://doi.org/10.1016/j.braindev.2008.07.010
Offringa M, Newton R (2013) Prophylactic drug management for febrile seizures in children (review). Evid Based Child Health 8:1376–1485. https://doi.org/10.1002/ebch.1921
Offringa M, Bossuyt PM, Lubsen J et al (1994) Risk factors for seizure recurrence in children with febrile seizures: a pooled analysis of individual patient data from five studies. J Pediatr 124:574–584
Bertille N, Purssell E, Hjelm N, Bilenko N, Chiappini E, de Bont EGPM, Kramer MS, Lepage P, Lava SAG, Mintegi S, Sullivan JE, Walsh A, Cohen JF, Chalumeau M (2018) Symptomatic management of febrile illnesses in children: a systematic review and meta-analysis of parents’ knowledge and behaviors and their evolution over time. Front Pediatr 6:279. https://doi.org/10.3389/fped.2018.00279
Pavlidou E, Tzitiridou M, Kontopoulos E, Panteliadis CP (2008) Which factors determine febrile seizure recurrence? A prospective study. Brain Dev 30:7–13. https://doi.org/10.1016/j.braindev.2007.05.001
Tosun A, Koturoglu G, Serdaroglu G, Polat M, Kurugol Z, Gokben S, Tekgul H (2010) Ratios of nine risk factors in children with recurrent febrile seizures. Pediatr Neurol 43:177–182. https://doi.org/10.1016/j.pediatrneurol.2010.05.007
Section on Clinical Pharmacology and Therapeutics; Committee on Drugs, Sullivan JE, Farrar HC (2011) Fever and antipyretic use in children. Pediatrics. 127:580–587. https://doi.org/10.1542/peds.2010-3852
Davis T (2013) NICE guideline: feverish illness in children—assessment and initial management in children younger than 5 years. Arch Dis Child Educ Pract Ed 98:232–235. https://doi.org/10.1136/archdischild-2013-304792
Chiappini E, Venturini E, Remaschi G et al (2017) 2016 Update of the Italian Pediatric Society Guidelines for management of fever in children. J Pediatr 180:177–183.e1. https://doi.org/10.1016/j.jpeds.2016.09.043
Clericetti CM, Milani GP, Bianchetti MG, Simonetti GD, Fossali EF, Balestra AM, Bozzini MA, Agostoni C, Lava SAG (2019) Systematic review finds that fever phobia is a worldwide issue among caregivers and healthcare providers. Acta Paediatr 108:1393–1397. https://doi.org/10.1111/apa.14739
Natsume J, Hamano S, Iyoda K, Kanemura H, Kubota M, Mimaki M, Niijima S, Tanabe T, Yoshinaga H, Kojimahara N, Komaki H, Sugai K, Fukuda T, Maegaki Y, Sugie H (2017) New guidelines for management of febrile seizures in Japan. Brain and Development 39:2–9. https://doi.org/10.1016/j.braindev.2016.06.003
Rosman NP, Colton T, Labazzo J, Gilbert PL, Gardella NB, Kaye EM, Bennekom CV, Winter MR (1993) A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures. N Engl J Med 329:79–84. https://doi.org/10.1056/nejm199307083290202
Graves RC, Oehler K, Tingle LE (2012) Febrile seizures: risks, evaluation, and prognosis. Am Fam Physician 85:149–153
Daneman D, McArthur JE (1978) The initial management of simple febrile seizures. N Z Med J 87:427–428
Offringa M, Newton R, Cozijnsen MA, Nevitt SJ (2017) Prophylactic drug management for febrile seizures in children. Cochrane Database Syst Rev 2:Cd003031. https://doi.org/10.1002/14651858.CD003031.pub3
Rosenbloom E, Finkelstein Y, Adams-Webber T, Kozer E (2013) Do antipyretics prevent the recurrence of febrile seizures in children? A systematic review of randomized controlled trials and meta-analysis. Eur J Paediatr Neurol 17:585–588. https://doi.org/10.1016/j.ejpn.2013.04.008
Murata S, Okasora K, Tanabe T, Ogino M, Yamazaki S, Oba C, Syabana K, Nomura S, Shirasu A, Inoue K, Kashiwagi M, Tamai H (2018) Acetaminophen and febrile seizure recurrences during the same fever episode. Pediatrics. 142(5):e20181009. https://doi.org/10.1542/peds.2018-1009
Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 343:d5928. https://doi.org/10.1136/bmj.d5928
Kim SY, Park JE, Lee YJ, Seo HJ, Sheen SS, Hahn S, Jang BH, Son HJ (2013) Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol 66:408–414. https://doi.org/10.1016/j.jclinepi.2012.09.016
Strengell T, Uhari M, Tarkka R, Uusimaa J, Alen R, Lautala P, Rantala H (2009) Antipyretic agents for preventing recurrences of febrile seizures: randomized controlled trial. Arch Pediatr Adolesc Med 163:799–804. https://doi.org/10.1001/archpediatrics.2009.137
Uhari M, Rantala H, Vainionpaa L, Kurttila R (1995) Effect of acetaminophen and of low intermittent doses of diazepam on prevention of recurrences of febrile seizures. J Pediatr 126:991–995
Van Esch A, Steyerberg EW, Moll HA, Offringa M, Hoes AW, Habbema JDF, Derksen-Lubsen G (2000) A study of the efficacy of antipyretic drugs in the prevention of febrile seizure recurrence. Ambulatory Child Health 6:19–26
van Stuijvenberg M, Derksen-Lubsen G, Steyerberg EW, Habbema JD, Moll HA (1998) Randomized, controlled trial of ibuprofen syrup administered during febrile illnesses to prevent febrile seizure recurrences. Pediatrics. 102:E51
Razieh F, Karbasi A, Sedighah (2010) Recurrence of febrile seizures in yazd shahid sadoughi hospital. Iran J Child Neurol 3:23–30
Van Esch A, Van Steensel-Moll HA, Steyerberg EW, Offringa M, Habbema JD, Derksen-Lubsen G (1995) Antipyretic efficacy of ibuprofen and acetaminophen in children with febrile seizures. Arch Pediatr Adolesc Med. 149:632–637
Schnaiderman D, Lahat E, Sheefer T, Aladjem M (1993) Antipyretic effectiveness of acetaminophen in febrile seizures: ongoing prophylaxis versus sporadic usage. Eur J Pediatr 152:747–749. https://doi.org/10.1007/BF01953992
Funding
This study was supported by a Grant-in-Aid for the National Center for Child Health and Development. The funding was used for literature search by an information specialist, ordering of full-text papers, and English language editing.
Author information
Authors and Affiliations
Contributions
Risa Hashimoto developed the concept of the study, designed the study, selected the eligible studies, collected the data, and summarized the data, wrote the initial draft of the manuscript, and revised it. Maiko Suto designed the study, selected the eligible studies, collected the data, summarized the data, and critically reviewed and revised the manuscript. Mariko Tsuji selected the eligible studies, collected the data, summarized the data, and critically reviewed and revised the manuscript. Hatoko Sasaki checked the results of summarized data and critically reviewed and revised the manuscript. Kenji Takehara designed the study and critically reviewed and revised the manuscript. Akira Ishiguro developed the concept of the study and critically reviewed and revised the manuscript. Masaya Kubota developed the concept of the study and critically reviewed and revised the manuscript. We had complete access to the study data that support the publication. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
Ethical approval was not required for this systematic review.
Additional information
Communicated by Gregorio Paolo Milani
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hashimoto, R., Suto, M., Tsuji, M. et al. Use of antipyretics for preventing febrile seizure recurrence in children: a systematic review and meta-analysis. Eur J Pediatr 180, 987–997 (2021). https://doi.org/10.1007/s00431-020-03845-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-020-03845-8